Clinical implications of restrictions in criteria for defining surgical site infections after mastectomy

Simple item page
dc.contributor.authorBediako-Bowan, A.A.A.
dc.contributor.authorWarren, D.K.
dc.contributor.authorNickel, K.B.
dc.contributor.authorFraser, V.J.
dc.contributor.authorOlsen, M.A.
dc.date.accessioned2021-12-15T15:08:54Z
dc.date.available2021-12-15T15:08:54Z
dc.date.issued2021
dc.descriptionResearch Articleen_US
dc.description.abstractMore than 50% of women with clinically apparent infection after mastectomy did not meet the 2020 National Healthcare Safety Network (NHSN) definition for surgical site infection (SSI). Implant loss was similar whether the 2020 NHSN SSI definition was met or not, suggesting equivalent adverse outcomes regardless of restriction to the surveillance definition.en_US
dc.identifier.otherhttps://doi.org/10.1017/ice.2020.1288
dc.identifier.urihttp://ugspace.ug.edu.gh/handle/123456789/37303
dc.language.isoen_USen_US
dc.publisherCambridge University Pressen_US
dc.titleClinical implications of restrictions in criteria for defining surgical site infections after mastectomyen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Clinical-implications-of-restrictions-in-criteria-for-defining-surgical-site-infections-after-mastectomyInfection-Control-and-Hospital-Epidemiology.pdf
Size:
340.23 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Department of Surgery